Literature DB >> 19240461

Telbivudine has activity against HIV-1.

Emma Low, Alison Cox, Mark Atkins, Mark Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19240461     DOI： 10.1097/QAD.0b013e3283262f09

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

2.  Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.

Authors:  Kai Lin; Sylwia Karwowska; Eric Lam; Kay Limoli; Thomas G Evans; Claudio Avila
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

3.  Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans.

Authors:  Noortje M van Maarseveen; Annemarie Mj Wensing; Dorien de Jong; Greg L Beilhartz; Aleksandr Obikhod; Sijia Tao; Marieke Pingen; Joop E Arends; Andy Im Hoepelman; Raymond F Schinazi; Matthias Götte; Monique Nijhuis
Journal:  Antivir Ther       Date:  2011

4.  Future directions in the treatment of HIV-HBV coinfection.

Authors:  David M Iser; Sharon R Lewin
Journal:  HIV Ther       Date:  2009-07-01

5.  Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.

Authors:  Marina B Klein; Jean-Guy Baril; Marc-André Charron; Claude Fortin; Richard Lalonde; Marie-France Matte; Marc Poliquin; Annie Talbot; Rachel Therrien; Cécile Tremblay; Benoît Trottier; Irina Tsarevsky; Jean-Pierre Villeneuve
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

6.  Safety and efficacy of telbivudine for the treatment of chronic hepatitis B.

Authors:  Melissa K Osborn
Journal:  Ther Clin Risk Manag       Date:  2009-10-12       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.